Clopidogrel market share – CRI Report https://www.cri-report.com market research vender! Thu, 02 Dec 2021 07:18:16 +0000 en-US hourly 1 https://www.cri-report.com/wp-content/uploads/2021/01/cropped-shcrilogo-c.jpg Clopidogrel market share – CRI Report https://www.cri-report.com 32 32 Investigation Report on Chinese Clopidogrel Market 2021-2025 https://www.cri-report.com/investigation-report-on-chinese-clopidogrel-market-2021-2025/ Fri, 23 Apr 2021 13:09:32 +0000 https://www.cri-report.com/?post_type=product&p=11229 According to CRI’s market research, the sales revenue of Clopidogrel in China has been decreasing since 2018, the sales value of Clopidogrel in China was approximately CNY680 million, and the CAGR is -21.9% in 2016 to 2020.

The post Investigation Report on Chinese Clopidogrel Market 2021-2025 first appeared on CRI Report.

]]> Clopidogrel is a medication that inhibits platelet aggregation and is mainly used to prevent atherosclerotic thrombosis. The original drug, Plavix, is developed by Sanofi. It enters the Chinese market in 2001. In addition to Sanofi, the other main manufacturers of Clopidogrel in the Chinese market are Salubris Pharmaceuticals, Lepu Pharmaceutical, and CSPC Ouyi Pharmaceutical.

According to CRI’s market research, the sales revenue of Clopidogrel in China has been decreasing since 2018, the sales value of Clopidogrel in China was approximately CNY680 million, and the CAGR is -21.9% in 2016 to 2020. The decrease in sales is mainly due to the impact of centralized procurement and the appearance of alternative drugs. Nevertheless, as the antithrombotic market keeps expanding, Clopidogrel will still have considerable annual sales in the short term. In addition, the price of Clopidogrel has been greatly reduced because of centralized procurement. Thus, some people may be more willing to choose Clopidogrel instead of other biosimilar drugs. CRI concludes that as the epidemic situation improves, Clopidogrel sales in China is expected to have a restorative growth, and it will also become more stable from 2022 to 2025.

Topics Covered:
-The impact of COVID-19 on China’s Clopidogrel market
– Sales value and volume of China’s Clopidogrel 2016-2020
– Competitive landscape of China’s Clopidogrel market
– Prices of Clopidogrel in China
– Prices of Clopidogrel in China by regions and manufacturers
– Analysis on factors affecting the development of China’s Clopidogrel market
– Prospect of China’s Clopidogrel market from 2021 to 2025

The post Investigation Report on Chinese Clopidogrel Market 2021-2025 first appeared on CRI Report.

]]>